WANG Chi, et al. Effects of oxymartine on expression of P-glycoprotein in HNE-1 cell line radiation therapy. [J]. Journal of Chongqing Medical University (1):16-19(2005)
WANG Chi, et al. Effects of oxymartine on expression of P-glycoprotein in HNE-1 cell line radiation therapy. [J]. Journal of Chongqing Medical University (1):16-19(2005) DOI: 10.13406/j.cnki.cyxb.2005.01.005.
Effects of oxymartine on expression of P-glycoprotein in HNE-1 cell line radiation therapy
Objective:To investigate the effects of oxymartine on cell growth and the changes of P-glycoprotein in HNE-1 cell line after exposed to fractionated X-irradiation.Methods:By MTT
the cell proliferation was observed both before X-irradiation and after X-irradiation conditions with the extent of vincristine
oxymartine and verapamil respectively.P-glycoprotein expression was tested by immunohistochemistory method SP.Results:(1)Vincristine
oxymartine and verapamil were capable of inhibiting cell growth on HNE-1 cell line and fractionated X-irradiated HNE-1(200)cell subline;(2)Vincristine was less inhibitory on cell growth in HNE-1(200)cell subline than HNE-1 cell line
and the difference had statistic significance;(3)P-glycoprotein expression in HNE-1 cell line was negative while HNE-1(200)cell subline positive;oxymartine with low inhibitory concentration could increase the expression of P-glycoprotein in HNE-1(200) cell subline
which is similar to that of verapamil.Conclusion:(1)Oxymartine is capable of inhibiting cell growth on HNE-1 cell line and fractionated X-irradiated HNE-1(200)cell subline;(2)HNE-I(200)cell subline is resistant to vincristine;(3)Oxymartine with low inhibitory concentration could increase the expression of P-glycoprotein in HNE-1(200)cell subline.which is similar to that of verapamil.
Effect of radiotherapy on P-glycoprotein expressionin nasopharyngeal squamous carcinoma
Expression of P-glycoprotein based on antigenic epitopes analyses
Expressions and significances of P-glycoprotein in childhood lymphoma and Wilms’ tumor
Related Author
LIU Yu
et al
陈鸿雁
邓红彬
徐曼
李圆圆
WANG Xiang-wei
et al
Related Institution
Department of Oncology,College of Clinical Medicine,Chongqing Medical University
重庆医科大学临床医院耳鼻喉科
重庆医科大学基础医学院病理教研室
Department of Urology,the Second Affiliated Hospital,the Third Military Medical University
Laboratory of Oncology,Ministry of Education Key Laboratory of Child Development and Disorders,Key Laboratory of Pediatrics in Chongqing,Chongqing International Science and Technology Cooperation Center for Child Development and Disorders